Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
85 studies found for:    Raynaud's
Show Display Options
Rank Status Study
1 Not yet recruiting Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon
Conditions: Primary Raynaud's Phenomenon (PR);   Genetic Mutations Causing PR;   Study of Patients and Their Relatives (With or Without Primary PR)
Intervention: Genetic: Demonstration of genetic mutations causing Raynaud's phenomenon
2 Recruiting Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: oral treprostinil;   Drug: Placebo
3 Completed
Has Results
Tadalafil for the Treatment of Raynaud's
Condition: Raynaud
Intervention: Drug: Tadalafil
4 Completed Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: placebo cream;   Drug: Glyceryl Trinitrate
5 Completed "As Required" Oral Sildenafil in Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: Sildenafil 40 mg;   Drug: Sildenafil 80 mg;   Drug: Placebo
6 Completed Acupressure for the Treatment of Raynaud's Phenomenon
Condition: Primary Raynaud's Phenomeon
Interventions: Other: Acupressure;   Other: Acupressure dilatation;   Behavioral: education
7 Unknown  Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
Condition: Raynaud Disease
Interventions: Drug: 0.9% nitroglycerin in TAM cream;   Drug: vehicle cream
8 Completed Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
Condition: Raynaud Disease
Intervention: Drug: Tadalafil
9 Unknown  A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon
Conditions: Raynaud's Disease;   Raynaud's Disease Secondary to Scleroderma;   Raynaud's Disease Secondary to Other Autoimmune Disease
Interventions: Drug: Nitroglycerin;   Drug: Topical AmphiMatrix
10 Completed Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon
Conditions: Raynaud's Disease;   Scleroderma;   Autoimmune Diseases
Intervention: Drug: Topical AmphiMatrix with nitroglycerin (MQX-503)
11 Completed Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Condition: Raynaud's Phenomenon Secondary to Systemic Sclerosis
Interventions: Drug: Selexipag;   Drug: Placebo
12 Completed PF-00489791 For The Treatment Of Raynaud's
Conditions: Raynaud's Disease;   Peripheral Vascular Disease
Intervention: Drug: PF-00489791
13 Completed Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
Condition: Raynaud's Disease
Interventions: Drug: SLx-2101;   Drug: Placebo
14 Completed Nova Cold Hands Raynaud's Disorder, a Disease Which Results in Decreased Blood Flow to the Hands and Feet.
Condition: Raynaud's Disease
Intervention: Radiation: Nova Flow Procedure
15 Completed Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
Condition: Raynaud Disease
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
16 Completed Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Topical organogel with nitroglycerin
17 Completed Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome
Condition: Raynaud Syndrome
Interventions: Drug: vardenafil;   Drug: Placebo
18 Completed
Has Results
Botulinum Toxin in the Treatment of Raynaud's
Condition: Raynaud's Syndrome
Intervention: Drug: botulinum toxin A
19 Terminated Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: ORM-12471 30mg;   Drug: ORM-12471;   Drug: placebo
20 Unknown  Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
Condition: Raynaud Disease
Intervention: Drug: Ginkgo biloba extract EGb 761®

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.